SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending sharply as its highly positive Phase 2 axSpA clinical data, robust financial updates, and institutional accumulation fuel intense investor anticipation, positioning sonelokimab as a potential best-in-class drug and igniting buyout speculation ahead of its upcoming Investor Day.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MULN symbol is trending due to significant community discussion surrounding a new 'Mullen Army' crypto token that leverages the controversial Mullen Automotive name; many investors are expressing strong skepticism, citing the stock's history of reverse splits and dilution, while some proponents claim the token offers utility and a revolutionary movement.

We're a deflationary token that builds utility around our BTC and ETH reserves.  Our main goal is to onboard newbies in the friendliest and safest way, that's why we launched our NFT book (definitely for dummies) on five chains one year ago.  Our new swap generates revenue that combined with our taxes allow us to grow at a slow but steady pace; We're completely sustainable because our monthly expenses are really low.

PiggyCoinBSC

PiggyCoinBSC ($PIGGYC) is trending as its community actively engages in X spaces, highlighting its unique tokenomics that include $BTC and $ETH strategic reserves, and the utility of its new multi-chain swap platform, Swappy. Despite strong bullish sentiment from supporters, some community members are voicing concerns and labeling it a scam.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is trending driven by institutional interest following a Grayscale S-1 filing for a NEAR Trust, alongside its expanding utility in cross-chain liquidity via 'NEAR Intents' and significant advancements in AI integration. Despite recent price volatility that has divided community sentiment, many are accumulating, banking on its reduced token inflation and strategic position in the AI-crypto ecosystem.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicor is surging following a substantial earnings beat and optimistic outlook for record revenues in 2026, fueled by its patented high-density power solutions crucial for AI data centers and successful IP licensing; however, some technical traders are eyeing consolidation after the rapid ascent.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is actively trending following FDA approval for Bysanti, an antipsychotic granted New Chemical Entity (NCE) status with patent protection until 2044. The community views this unexpected long-term exclusivity as a transformative event, anticipating significant analyst re-ratings and potential multi-billion dollar buyout offers from major pharmaceutical companies seeking to address their own patent cliffs, alongside excitement for Vanda's broader pipeline, including a GLP-1 related nausea drug.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

Bitdeer is trending amid a strategic pivot to AI/HPC cloud services and data center expansion, supported by solid Q4 revenue and a large capital raise; however, the community is actively debating the impact of this substantial dilution and the sale of all its Bitcoin holdings, leading to significant stock volatility.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy ($SWEAT) is trending amid active community discussion regarding its "move-to-earn" utility and speculation on its future valuation. Investors are divided between those accumulating with long-term hopes for a rebound and those cautioning against its volatile nature, often noting its association with NEAR Protocol.

NEOS ETF Trust - NEOS Real Estate High Income ETF

NEOS Real Estate High Income ETF

NEOS Real Estate High Income ETF (IYRI) is trending as investors actively discuss its consistent high monthly distributions and attractive tax-efficient yield, often comparing its income potential favorably to other REITs, particularly given its strategy of combining real estate exposure with options income.

Vanguard Group, Inc. - Vanguard Value ETF

Vanguard Value ETF

The Vanguard Value ETF ($VTV) is trending as value stocks surge to new all-time highs, signaling a notable market rotation and outperformance compared to growth sectors. The community is actively discussing VTV as a strong, long-term holding poised for continued strength amidst shifting market dynamics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tyra Biosciences to Participate in Upcoming Investor Conferences

Tyra Biosciences to Participate in Upcoming Investor Conferences Tyra Biosciences to Participate in Upcoming Investor Conferences PR Newswire CARLSBAD, Calif., Feb. 19, 2026 CARLSBAD, Calif., Feb...

Promising Growth Stocks To Watch Today - February 18th

Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Hercules Capital, Tyra Biosciences, and Trinity Capital are the seven Growth stocks to watch today, according to MarketBeat's...

Wedbush Increases Tyra Biosciences (NASDAQ:TYRA) Price Target to $53.00

Wedbush raised their price target on Tyra Biosciences from $37.00 to $53.00 and gave the company an "outperform" rating in a report on Friday...

Tyra Biosciences (NASDAQ:TYRA) Sets New 12-Month High - Time to Buy?

Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month High - Here's What Happened...

Best Growth Stocks To Research - February 12th

Prologis, Ascendis Pharma A/S, Teledyne Technologies, Tyra Biosciences, Hercules Capital, Hamilton Lane, and Trinity Capital are the seven Growth stocks to watch today, according to MarketBeat's...

Growth Stocks To Follow Today - February 11th

Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Tyra Biosciences are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are...

Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) have earned a consensus rating of "Moderate Buy" from the nine research firms that are covering the stock, Marketbeat reports. One...

AlphaQuest LLC Has $421,000 Holdings in Tyra Biosciences, Inc. $TYRA

AlphaQuest LLC reduced its stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 58.9% in the third quarter, according to its most recent filing with the SEC. The institutional...

Growth Stocks To Watch Now - February 3rd

Prologis, Hamilton Lane, Teledyne Technologies, Hercules Capital, Ascendis Pharma A/S, Digital Turbine, and Tyra Biosciences are the seven Growth stocks to watch today, according to MarketBeat's...

Jefferies Financial Group Forecasts Strong Price Appreciation for Tyra Biosciences (NASDAQ:TYRA) Stock

Jefferies Financial Group raised their price target on Tyra Biosciences from $32.00 to $43.00 and gave the company a "buy" rating in a research report on Tuesday...

Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SNÅP, enables the rapid and precise refinement of structural design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA is developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family members, which are altered in approximately 7% of all cancers. The company was founded by Daniel Bensen and Todd Harris on August 2, 2018 and is headquartered in Carlsbad, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.54	--	--	N/A
Q3 '25	-$0.50	-$0.50	-0.50%	MISSED
Q2 '25	-$0.53	-$0.47	11.22%	BEAT
Q1 '25	-$0.49	-$0.47	3.25%	BEAT
Q4 '24	-$0.47	-$0.43	9.25%	BEAT

TYRA
Tyra Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest TYRA News

TYRATyra Biosciences Inc